Tag: Dr. Alan Sandler

Mirati Therapeutics secures UK approval for KRAZATI in advanced NSCLC

businessnewstoday- November 4, 2023

Mirati Therapeutics, Inc. (NASDAQ: MRTX), an innovative biotechnology company, has received conditional authorization from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) for its ... Read More